EVH — Evolent Health Cashflow Statement
0.000.00%
Last trade - 00:00- $1.05bn
- $1.60bn
- $2.55bn
Annual cashflow statement for Evolent Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -334 | -37.6 | -19.2 | -113 | -61.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 313 | 30.5 | 44.5 | 125 | 78.1 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -55.3 | -13.6 | -58.5 | 100 | -113 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -16.2 | 38.7 | -11.6 | 143 | 18.8 |
| Capital Expenditures | -31.8 | -25 | -47.5 | -28.7 | -24.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 293 | 9.2 | -212 | -387 | -38 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 261 | -15.8 | -259 | -416 | -62.9 |
| Financing Cash Flow Items | -27.9 | 56 | -92.7 | -63.7 | -42.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -11.9 | -29.5 | 132 | 281 | -0.565 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 233 | -6.64 | -140 | 8.3 | -45 |